MicroRNA Dysregulation in Prostate Cancer.
Vlad Horia SchitcuLajos-Zsolt RadulyAndreea NutuOana ZanoagaCristina CiocanVlad Cristian MunteanuRoxana CojocneanuBogdan PetrutIoan ComanCornelia BraicuIoana Berindan-NeagoePublished in: Pharmacogenomics and personalized medicine (2022)
In this pilot study, we provide evidence on miRNA dysregulation and its association with key functional components of the PRAD landscape, where an important role is acted by miR-20b-5p, miR-542-5p, or the oncogenic cluster miR-183-96-182.